Office of the Director, National Institutes of Health; Notice of Meeting, 19628-19629 [2021-07612]
Download as PDF
<![CDATA[
19628
Federal Register / Vol. 86, No. 70 / Wednesday, April 14, 2021 / Notices
TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN
Number of
disclosures per
respondent
Number of
respondents
.109(d) [Pre-2018 and 2018 Requirements]—Written notification of ........................................................................
IRB approval or disapproval of research ...........................
.46.116(a) and (b) (Pre-2018 Requirements)/.46.116 (b),
(c) and (d) [2018 Requirements]—Elements of informed consent and broad consent ...............................
.46.116(h)—[2018 Requirements]—Posting clinical trial
consent form ...................................................................
.117(a) [Pre-2018 and 2018 Requirements]—Documentation of informed consent .................................................
.117(c)(2) [Pre-2018 and 2018 Requirements]—Written
statement about the research when informed consent
documentation is waived ................................................
Total ............................................................................
Sherrrette A. Funn,
Paperwork Reduction Act Reports Clearance
Office, Office of the Secretary.
[FR Doc. 2021–07622 Filed 4–13–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
VerDate Sep<11>2014
17:22 Apr 13, 2021
Jkt 253001
Total hours
25
150,000
0.5
75,000
6,000
25
150,000
0.5
75,000
100
3
300
0.5
150
6,000
25
150,000
0.5
75,000
6,000
10
60,000
1
60,000
........................
..........................
510,300
........................
285,150
(301) 496–0726, prenticekj@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 8, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–07610 Filed 4–13–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Council of Councils.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
PO 00000
Average
burden per
disclosure
6,000
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Risk, Prevention
and Health Behavior Integrated Review
Group Addiction Risks and Mechanisms
Study Section.
Date: June 14–15, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Prentice,
Ph.D., Scientific Review Officer, Center
for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room
3112, MSC 7808, Bethesda, MD 20892,
Total annual
disclosures
Frm 00027
Fmt 4703
Sfmt 4703
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: May 20, 2021.
Time: 11:00 a.m. to 4:15 p.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; Scientific
Talks and Other Business of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Name of Committee: Council of Councils.
Closed: May 21, 2021.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Open: May 21, 2021.
Time: 11:00 a.m. to 4:05 p.m.
Agenda: NIH Program Updates; Scientific
Talks and Other Business of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Council of
Councils, Director, Office of Research
Infrastructure Programs, Division of Program
Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda,
MD 20892, GriederF@mail.nih.gov. 301–435–
0744.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
E:\FR\FM\14APN1.SGM
14APN1
Federal Register / Vol. 86, No. 70 / Wednesday, April 14, 2021 / Notices
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: April 9, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–07612 Filed 4–13–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: May 18, 2021.
Open: 9:30 a.m. to 12:30 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda, MD 20892–4872, https://
videocast.nih.gov (Virtual Meeting).
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast https://videocast.nih.gov. Please
VerDate Sep<11>2014
17:22 Apr 13, 2021
Jkt 253001
19629
note, the link to the videocast meeting will
be posted within a week of the meeting date.
Any member of the public may submit
written comments no later than 15 days after
the meeting.
Closed: 2:00 p.m. to 3:10 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda, MD 20892–4872 (Virtual Meeting).
Contact Person: Melinda Nelson, Director,
Office of Extramural Operations, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda, MD 20892–4872, (301) 435–5278,
nelsonm@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Contact Person: Noffisat Oki, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 240–627–3648,
noffisat.oki@nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biomaterials and Biointerfaces Study
Section.
Date: June 10–11, 2021.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph D Mosca, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 408–
9465, moscajos@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 8, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: April 8, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–07609 Filed 4–13–21; 8:45 am]
[FR Doc. 2021–07611 Filed 4–13–21; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institutes of Health
Federal Emergency Management
Agency
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Modeling and Analysis of Biological
Systems Study Section.
Date: June 2–3, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
[Docket ID: FEMA–2021–0012]
Assistance to Firefighters Grant
Program
Federal Emergency
Management Agency (FEMA),
Department of Homeland Security
(DHS).
ACTION: Notice.
AGENCY:
Pursuant to the Federal Fire
Prevention and Control Act of 1974, as
amended, the Administrator of FEMA is
publishing this notice describing the
fiscal year (FY) 2020 Assistance to
Firefighters Grant (AFG) Program
application process, deadlines, and
award selection criteria. This notice
explains the differences, if any, between
these guidelines and those
recommended by representatives of the
national fire service leadership during
the annual meeting of the Criteria
Development Panel, which was held
December 11, 2019. The application
period for the FY 2020 AFG Program
was January 4, 2021 through February
12, 2021, and was announced on the
AFG website at: https://www.fema.gov/
SUMMARY:
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 86, Number 70 (Wednesday, April 14, 2021)]
[Notices]
[Pages 19628-19629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07612]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Council of
Councils.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The open session will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov).
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4), and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Open: May 20, 2021.
Time: 11:00 a.m. to 4:15 p.m.
Agenda: Call to Order and Introductions; Announcements and
Updates; Scientific Talks and Other Business of the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Name of Committee: Council of Councils.
Closed: May 21, 2021.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Open: May 21, 2021.
Time: 11:00 a.m. to 4:05 p.m.
Agenda: NIH Program Updates; Scientific Talks and Other Business
of the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Franziska Grieder, D.V.M., Ph.D., Executive
Secretary, Council of Councils, Director, Office of Research
Infrastructure Programs, Division of Program Coordination, Planning,
and Strategic Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda, MD 20892,
[email protected]. 301-435-0744.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council of Council's home
page at https://dpcpsi.nih.gov/council/ where an agenda will be
posted before the meeting date.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research
[[Page 19629]]
Training Award; 93.22, Clinical Research Loan Repayment Program for
Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment
Program for Research Generally; 93.39, Academic Research Enhancement
Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate Scholarship Program for
Individuals from Disadvantaged Backgrounds, National Institutes of
Health, HHS)
Dated: April 9, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-07612 Filed 4-13-21; 8:45 am]
BILLING CODE 4140-01-P
